Skip to main content
NASDAQ:CKPT

Checkpoint Therapeutics SEC Filings & 10K Form

$2.31
-0.07 (-2.94 %)
(As of 05/14/2021 01:32 PM ET)
Add
Compare
Today's Range
$2.31
$2.41
50-Day Range
$2.36
$3.21
52-Week Range
$1.56
$5.38
Volume12,303 shs
Average Volume1.29 million shs
Market Capitalization$173.74 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

SEC Filings

Checkpoint Therapeutics (NASDAQ:CKPT) SEC Filings

DateFilerForm TypeView
05/07/2021
4:09 PM
BlackRock Inc. (Filed by)
Checkpoint Therapeutics (Subject)
Form SC 13G/A
05/06/2021
3:31 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
5:10 AM
Checkpoint Therapeutics (Filer)
Form DEFA14A
04/30/2021
5:08 AM
Checkpoint Therapeutics (Filer)
Form DEF 14A
04/20/2021
3:16 PM
Checkpoint Therapeutics (Filer)
Form PRE 14A
03/12/2021
7:35 AM
Checkpoint Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2021
4:17 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2021
7:16 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
7:16 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
8:18 AM
Checkpoint Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/23/2020
8:30 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
11:15 PM
Checkpoint Therapeutics (Filer)
Form EFFECT
12/17/2020
4:20 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
4:18 PM
Checkpoint Therapeutics (Filer)
Form 424B5
11/27/2020
4:16 PM
Checkpoint Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/27/2020
3:03 PM
Checkpoint Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/06/2020
3:11 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
3:31 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2020
4:28 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2020
9:08 AM
Checkpoint Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
09/21/2020
4:26 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2020
4:02 PM
Checkpoint Therapeutics (Filer)
Form 424B5
09/18/2020
9:10 AM
Checkpoint Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
09/17/2020
4:25 PM
Checkpoint Therapeutics (Filer)
Form 424B5
09/17/2020
4:15 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
5:39 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2020
3:30 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
7:40 AM
Checkpoint Therapeutics (Filer)
Form DEFA14A
04/24/2020
8:01 AM
Checkpoint Therapeutics (Filer)
Form DEFA14A
04/24/2020
8:00 AM
Checkpoint Therapeutics (Filer)
Form DEF 14A
04/21/2020
7:31 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
4:14 PM
Checkpoint Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2020
6:01 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
6:01 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
12:22 PM
BlackRock Inc. (Filed by)
Checkpoint Therapeutics (Subject)
Form SC 13G/A
11/22/2019
7:00 AM
Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
7:31 AM
Checkpoint Therapeutics (Filer)
Form 424B5
11/20/2019
3:50 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:26 PM
Checkpoint Therapeutics (Filer)
Form 424B5
11/07/2019
3:45 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
4:01 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:35 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:50 PM
Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:49 PM
Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:48 PM
Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:47 PM
Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:46 PM
Boilen Scott (Reporting)
Checkpoint Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:46 PM
Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:17 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
5:59 AM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
4:13 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
6:45 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
5:34 AM
Checkpoint Therapeutics (Filer)
Form DEFA14A
04/30/2019
5:30 AM
Checkpoint Therapeutics (Filer)
Form DEF 14A
04/25/2019
4:01 PM
Checkpoint Therapeutics (Filer)
Form CT ORDER
04/19/2019
3:19 PM
Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Form SC 13D/A
03/15/2019
6:40 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2019
3:31 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:30 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
11:23 AM
Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2018
3:32 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2018
7:33 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2018
3:31 PM
Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2018
4:01 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
6:31 AM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
3:42 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/15/2018
4:26 PM
Boilen Scott (Reporting)
Checkpoint Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:25 PM
Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:23 PM
Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:22 PM
Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:21 PM
Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:43 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
3:43 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
3:20 PM
Checkpoint Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2018
6:02 AM
Checkpoint Therapeutics (Filer)
Form DEFA14A
04/30/2018
6:01 AM
Checkpoint Therapeutics (Filer)
Form DEF 14A
04/20/2018
6:01 AM
Checkpoint Therapeutics (Filer)
Form PRE 14A
03/16/2018
7:01 AM
Checkpoint Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2018
3:14 PM
Checkpoint Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
4:21 PM
Checkpoint Therapeutics (Filer)
Form 424B5
03/07/2018
3:02 PM
Checkpoint Therapeutics (Filer)
Form 424B5
02/01/2018
5:41 PM
Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2018
5:40 PM
Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2017
11:15 PM
Checkpoint Therapeutics (Filer)
Form EFFECT
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.